FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2418381621> ?p ?o ?g. }

• W2418381621 endingPage "8" @default.
• W2418381621 startingPage "213" @default.
• W2418381621 abstract "To observe the effects of blood purification in the treatment of burn sepsis, in order to provide evidence for its application.Twenty-seven patients with burn sepsis admitted to our burn ward from June 2012 to December 2013, conforming to the study criteria, were divided into conventional treatment group (CT, n = 15) and blood purification group (BP, n = 12) according to the random number table. After the diagnosis of sepsis was confirmed, patients in group CT received CT, while patients in group BP received both CT and continuous veno-venous hemodiafiltration for 48 hours. At the time of diagnosis of sepsis (before treatment) and post treatment hour (PTH) 24 and 48, levels of blood lactate and PaO2 were analyzed with blood gas analyzer, and the oxygenation index (OI) was calculated; blood sodium, blood glucose, blood urea nitrogen (BUN), creatinine, white blood cell count (WBC), procalcitonin (PCT) were determined; acute physiology and chronic health evaluation (APACHE) II score was estimated basing on the body temperature, respiratory rate, mean arterial pressure, PaO2, and blood pH values. The levels of TNF-α, IL-8, and IL-6 in serum were determined by ELISA. Data were processed with Fisher's exact test, t test, analysis of variance for repeated measurement, LSD- t test, and LSD test.(1) The levels of blood lactate of patients in group BP were significantly lower than those of group CT at PTH 24 and 48 (with t values respectively 1.62 and 2.44, P values below 0.05). Compared with that detected before treatment, the level of blood lactate in group BP was significantly decreased at PTH 48 (P < 0.05). The OI values of patients in group BP at PTH 24 and 48 [(247 ± 30), (288 ± 41) mmHg, 1 mmHg = 0.133 kPa] were significantly higher than those of group CT [(211 ± 32), (212 ± 30) mmHg, with t values respectively 3.02 and 5.63, P values below 0.01]. Compared with that detected before treatment, the OI values of patients in group BP at PTH 24 and 48 were significantly higher (P values below 0.01). (2) Compared with those of group CT at PTH 24 and 48, the levels of blood sodium, BUN, and creatinine were significantly lower (with t values from 1.74 to 6.75, P < 0.05 or P < 0.01), while the level of blood glucose was approximately the same (with t values respectively -0.92, -0.38, P values above 0.05) in group BP. Compared with those detected before treatment, the levels of blood sodium, BUN, and creatinine of group BP at PTH 24 and 48 were significantly lower (P < 0.05 or P < 0.01). (3) The levels of WBC and PCT of patients in group BP at PTH 24 and 48 were significantly lower than those of group CT (with t values from 2.11 to 6.63, P < 0.05 or P < 0.01). Compared with those detected before treatment, the levels of WBC and PCT of patients in group BP at PTH 24 and 48 were significantly lower (P < 0.05 or P < 0.01). (4) The APACHE II scores of patients in group BP at PTH 24 and 48 [(18.7 ± 2.6) and (16.7 ± 3.0) scores] were significantly lower than those of group CT [(23.1 ± 1.6) and (25.5 ± 1.6) scores, with t values respectively 5.44 and 9.87, P values below 0.01]. Compared with those calculated before treatment, the APACHE II scores of patients in group CT were significantly increased (P < 0.05 or P < 0.01), while those in group BP were decreased at PTH 24 and 48 (P < 0.05 or P < 0.01). (5) The levels of TNF-α, IL-6, and IL-8 in serum of patients in group BP at PTH 24 and 48 were significantly lower than those of group CT (with t values from 6.12 to 19.78, P values below 0.01). Compared with those detected before treatment, the levels of TNF-α, IL-6, and IL-8 in serum of group BP at PTH 24 and 48 were significantly decreased (with P values below 0.01).BP+CT is effective in improving organ function, correcting the disorder of internal environment, and controlling inflammation. Therefore, BP is an important method in the treatment of burn sepsis." @default.
• W2418381621 created "2016-06-24" @default.
• W2418381621 creator A5008770552 @default.
• W2418381621 creator A5015728129 @default.
• W2418381621 creator A5038836690 @default.
• W2418381621 creator A5058399674 @default.
• W2418381621 creator A5076170801 @default.
• W2418381621 date "2014-06-01" @default.
• W2418381621 modified "2023-10-16" @default.
• W2418381621 title "[Effects of blood purification in the treatment of patients with burn sepsis]." @default.
• W2418381621 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25174381" @default.
• W2418381621 hasPublicationYear "2014" @default.
• W2418381621 type Work @default.
• W2418381621 sameAs 2418381621 @default.
• W2418381621 citedByCount "2" @default.
• W2418381621 countsByYear W24183816212017 @default.
• W2418381621 countsByYear W24183816212018 @default.
• W2418381621 crossrefType "journal-article" @default.
• W2418381621 hasAuthorship W2418381621A5008770552 @default.
• W2418381621 hasAuthorship W2418381621A5015728129 @default.
• W2418381621 hasAuthorship W2418381621A5038836690 @default.
• W2418381621 hasAuthorship W2418381621A5058399674 @default.
• W2418381621 hasAuthorship W2418381621A5076170801 @default.
• W2418381621 hasConcept C10936531 @default.
• W2418381621 hasConcept C126322002 @default.
• W2418381621 hasConcept C126894567 @default.
• W2418381621 hasConcept C141071460 @default.
• W2418381621 hasConcept C2778176769 @default.
• W2418381621 hasConcept C2778384902 @default.
• W2418381621 hasConcept C2778488018 @default.
• W2418381621 hasConcept C2780306776 @default.
• W2418381621 hasConcept C71924100 @default.
• W2418381621 hasConcept C84393581 @default.
• W2418381621 hasConcept C90924648 @default.
• W2418381621 hasConceptScore W2418381621C10936531 @default.
• W2418381621 hasConceptScore W2418381621C126322002 @default.
• W2418381621 hasConceptScore W2418381621C126894567 @default.
• W2418381621 hasConceptScore W2418381621C141071460 @default.
• W2418381621 hasConceptScore W2418381621C2778176769 @default.
• W2418381621 hasConceptScore W2418381621C2778384902 @default.
• W2418381621 hasConceptScore W2418381621C2778488018 @default.
• W2418381621 hasConceptScore W2418381621C2780306776 @default.
• W2418381621 hasConceptScore W2418381621C71924100 @default.
• W2418381621 hasConceptScore W2418381621C84393581 @default.
• W2418381621 hasConceptScore W2418381621C90924648 @default.
• W2418381621 hasIssue "3" @default.
• W2418381621 hasLocation W24183816211 @default.
• W2418381621 hasOpenAccess W2418381621 @default.
• W2418381621 hasPrimaryLocation W24183816211 @default.
• W2418381621 hasRelatedWork W2102144521 @default.
• W2418381621 hasRelatedWork W2124611705 @default.
• W2418381621 hasRelatedWork W2154740531 @default.
• W2418381621 hasRelatedWork W2316559152 @default.
• W2418381621 hasRelatedWork W2418381621 @default.
• W2418381621 hasRelatedWork W2665927062 @default.
• W2418381621 hasRelatedWork W2943811117 @default.
• W2418381621 hasRelatedWork W3029270103 @default.
• W2418381621 hasRelatedWork W3032477918 @default.
• W2418381621 hasRelatedWork W64939267 @default.
• W2418381621 hasVolume "30" @default.
• W2418381621 isParatext "false" @default.
• W2418381621 isRetracted "false" @default.
• W2418381621 magId "2418381621" @default.
• W2418381621 workType "article" @default.